Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Current Assets (2020 - 2025)

RxSight (RXST) has disclosed Current Assets for 6 consecutive years, with $287.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 2.17% year-over-year to $287.5 million, compared with a TTM value of $287.5 million through Dec 2025, down 2.17%, and an annual FY2025 reading of $287.5 million, down 2.17% over the prior year.
  • Current Assets was $287.5 million for Q4 2025 at RxSight, up from $283.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $293.8 million in Q4 2024 and bottomed at $75.5 million in Q2 2021.
  • Average Current Assets over 5 years is $205.3 million, with a median of $180.4 million recorded in 2023.
  • The sharpest move saw Current Assets surged 116.31% in 2021, then fell 25.32% in 2022.
  • Year by year, Current Assets stood at $176.3 million in 2021, then dropped by 23.68% to $134.6 million in 2022, then increased by 25.16% to $168.4 million in 2023, then soared by 74.47% to $293.8 million in 2024, then dropped by 2.17% to $287.5 million in 2025.
  • Business Quant data shows Current Assets for RXST at $287.5 million in Q4 2025, $283.9 million in Q3 2025, and $283.9 million in Q2 2025.